메뉴 건너뛰기




Volumn 119, Issue 18, 2012, Pages 4337-4338

Bcl-xL-inhibitory BH3 mimetic ABT-737 depletes platelet calcium stores

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; BH3 PROTEIN; CALCIUM; PROTEIN BCL XL; ANILINE DERIVATIVE; ANTITHROMBOCYTIC AGENT; PROTEIN BCL X; SULFONAMIDE;

EID: 84860833041     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-413070     Document Type: Letter
Times cited : (16)

References (6)
  • 1
    • 79959828108 scopus 로고    scopus 로고
    • BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation
    • Vogler M, Hamali HA, Sun XM, et al. BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood. 2011;117(26):7145-7154.
    • (2011) Blood , vol.117 , Issue.26 , pp. 7145-7154
    • Vogler, M.1    Hamali, H.A.2    Sun, X.M.3
  • 2
    • 80051606228 scopus 로고    scopus 로고
    • Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets
    • Schoenwaelder SM, Jarman KE, Gardiner EE, et al. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood. 2011;118(6):1663-1674.
    • (2011) Blood , vol.118 , Issue.6 , pp. 1663-1674
    • Schoenwaelder, S.M.1    Jarman, K.E.2    Gardiner, E.E.3
  • 3
    • 67649541305 scopus 로고    scopus 로고
    • Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function
    • Schoenwaelder SM, Yuan Y, Josefsson EC, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood. 2009;114(3):663-666.
    • (2009) Blood , vol.114 , Issue.3 , pp. 663-666
    • Schoenwaelder, S.M.1    Yuan, Y.2    Josefsson, E.C.3
  • 4
    • 78649630259 scopus 로고    scopus 로고
    • Navitoclax, a targeted highaffinity inhibitor of BCL-2, in lymphoid malignancies: A phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
    • Wilson WH, O'Connor OA, Czuczman MS, et al. Navitoclax, a targeted highaffinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol. 2010;11(12):1149-1159.
    • (2010) Lancet Oncol , vol.11 , Issue.12 , pp. 1149-1159
    • Wilson, W.H.1    O'Connor, O.A.2    Czuczman, M.S.3
  • 5
    • 84856603735 scopus 로고    scopus 로고
    • Bcl-xL-inhibitory BH3 mimetics (ABT-737 or ABT-263) and the modulation of cytosolic calcium flux and platelet function
    • Schoenwaelder SM, Jackson SP. Bcl-xL-inhibitory BH3 mimetics (ABT-737 or ABT-263) and the modulation of cytosolic calcium flux and platelet function. Blood. 2012;119(5):1320-1321.
    • (2012) Blood , vol.119 , Issue.5 , pp. 1320-1321
    • Schoenwaelder, S.M.1    Jackson, S.P.2
  • 6
    • 0021895138 scopus 로고
    • 2+ indicators with greatly improved fluorescence properties
    • Grynkiewicz G, Poenie M, Tsien RY.Anew generation of Ca2+indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260(6):3440-3450. (Pubitemid 15114340)
    • (1985) Journal of Biological Chemistry , vol.260 , Issue.6 , pp. 3440-3450
    • Grynkiewicz, G.1    Poenie, M.2    Tsien, R.Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.